Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD

被引：74
作者：
Flood, V. H. [1 ]
Lederman, C. A. [2 ]
Wren, J. S. [3 ]
Christopherson, P. A. [3 ]
Friedman, K. D. [3 ]
Hoffmann, R. G. [4 ]
Montgomery, R. R. [1 ,3 ]
机构：
[1] Med Coll Wisconsin, Dept Pediat, Div Hematol Oncol, Milwaukee, WI 53226 USA
[2] Dickstein Canc Ctr, White Plains, NY USA
[3] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA
[4] Med Coll Wisconsin, Dept Pediat, Div Quantitat Hlth Sci, Milwaukee, WI 53226 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2010年 / 8卷 / 06期
关键词：
VON-WILLEBRAND-FACTOR; DISEASE; SITE; RISTOCETIN; PLATELETS; ASSAY;
D O I：
10.1111/j.1538-7836.2010.03869.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1431 / 1433
页数：3
相关论文
共 14 条
  • [1] von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen
    Bonnefoy, A.
    Romijn, R. A.
    Vandervoort, P. A. H.
    Van Rompaey, I.
    Vermylen, J.
    Hoylaerts, M. F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (10) : 2151 - 2161
  • [2] AN ELISA TEST FOR THE BINDING OF VONWILLEBRAND ANTIGEN TO COLLAGEN
    BROWN, JE
    BOSAK, JO
    [J]. THROMBOSIS RESEARCH, 1986, 43 (03) : 303 - 311
  • [3] INTERACTION OF THE VON-WILLEBRAND-FACTOR (VWF) WITH COLLAGEN - LOCALIZATION OF THE PRIMARY COLLAGEN-BINDING SITE BY ANALYSIS OF RECOMBINANT VWF A DOMAIN POLYPEPTIDES
    CRUZ, MA
    YUAN, HB
    LEE, JR
    WISE, RJ
    HANDIN, RI
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) : 10822 - 10827
  • [4] von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: A 15-year journey
    Favaloro, EJ
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (02) : 191 - 202
  • [5] Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function
    Flood, V. H.
    Friedman, K. D.
    Gill, J. C.
    Morateck, P. A.
    Wren, J. S.
    Scott, J. P.
    Montgomery, R. R.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (11) : 1832 - 1839
  • [6] Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin - but not botrocetin-mediated binding of von Willebrand factor to platelets
    Hillery, CA
    Mancuso, DJ
    Sadler, JE
    Ponder, JW
    Jozwiak, MA
    Christopherson, PA
    Gill, JC
    Scott, JP
    Montgomery, RR
    [J]. BLOOD, 1998, 91 (05) : 1572 - 1581
  • [7] von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)
    Nichols, W. L.
    Hultin, M. B.
    James, A. H.
    Manco-Johnson, M. J.
    Montgomery, R. R.
    Ortel, T. L.
    Rick, M. E.
    Sadler, J. E.
    Weinstein, M.
    Yawn, B. P.
    [J]. HAEMOPHILIA, 2008, 14 (02) : 171 - 232
  • [8] PARETI FI, 1987, J BIOL CHEM, V262, P13835
  • [9] Ribba AS, 2001, THROMB HAEMOSTASIS, V86, P848
  • [10] Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor
    Riddell, Anne F.
    Gomez, Keith
    Millar, Carolyn M.
    Mellars, Gillian
    Gill, Saher
    Brown, Simon A.
    Sutherland, Megan
    Laffan, Mike A.
    McKinnon, Thomas A. J.
    [J]. BLOOD, 2009, 114 (16) : 3489 - 3496
12